AstraZeneca to buy drug developer CinCor Pharma AstraZeneca has said it has struck a deal to buy US-based drug developer CinCor Pharma for up to $1.8 billion to increase its stock of … Business • 09 Jan
AstraZeneca tops estimates buoyed by cancer drug sales AstraZeneca has today topped analysts' expectations for third-quarter profit and revenue, helped by sales of its key cancer drugs, and raised its full-year adjusted earnings … Business • 10 Nov 22
AstraZeneca's Alexion to invest €65m in Irish operation AstraZeneca's Rare Disease group, Alexion, is investing €65m in new and enhanced capabilities across its sites in College Park in Blanchardstown and Monksland Industrial Park … Business • 24 Jun 22
AstraZeneca sees higher 2022 sales but Covid boost dips AstraZeneca has forecast higher 2022 sales and raised its annual dividend for the first time in a decade after beating fourth-quarter profit expectations, but warned … Business • 10 Feb 22
AstraZeneca makes over $1 billion in Q3 vaccine sales AstraZeneca has today posted $1.05 billion in Covid-19 vaccine sales for the third quarter and the not-for-profit vaccine added one cent to profit in the … Business • 12 Nov 21
AstraZeneca to create 100 jobs in new Dublin plant Biopharmaceutical company AstraZeneca is planning to set up a next-generation active pharmaceutical ingredient (API) manufacturing facility in Dublin to ensure its global supply network is … Business • 21 Sep 21
Nerve disorder listed as 'rare' side effect of AZ jab The European Medicines Agency has listed the neurological disorder Guillain-Barre syndrome, which can cause temporary paralysis, as a "very rare" side effect of the AstraZeneca … Coronavirus • 09 Sep 21
AstraZeneca, EU reach settlement on vaccine delivery The European Union and AstraZeneca have resolved their differences over the troubled delivery of Covid-19 vaccines, according to a European Commission statement. Coronavirus • 03 Sep 21
Charles River Laboratories in €8m expansion in Ballina Charles River Laboratories International has announced plans for an €8m expansion of its testing capabilities at its Ballina, Co Mayo site which will create up … Business • 26 Jul 21
UK nod paves way for AstraZeneca-Alexion deal to close AstraZeneca's $39 billion buyout of US-based rare diseases business Alexion is expected to close next week as Britain's competition watchdog cleared the deal today. Business • 14 Jul 21
Delayed doses of AstraZeneca jab boost immunity - study Delayed second and third doses of the AstraZeneca vaccine boost immunity against Covid-19, a study by Oxford University, which developed the jab with the British-Swedish … Coronavirus • 28 Jun 21
Duterte threatens to jail those who refuse vaccine Philippines President Rodrigo Duterte, frustrated by the slow pace of Covid-19 vaccinations in his country, threatened people who refuse to get inoculated with jail or … Coronavirus • 22 Jun 21
AstraZeneca hits snag in Covid-19 drug development Covid vaccine-maker AstraZeneca has revealed it had hit a setback in trials of a treatment for the coronavirus. Coronavirus • 15 Jun 21
EU seeks penalties against AstraZeneca over dose delays The European Union has asked a Belgian court to impose penalties running to millions of euros per day on AstraZeneca for Covid-19 vaccine doses it … Coronavirus • 26 May 21
UK under-40s to get alternative to AstraZeneca jab UK regulators said under-40s are to be offered an alternative to the Oxford/AstraZeneca coronavirus vaccine. Coronavirus • 07 May 21
AstraZeneca Q1 Covid-19 vaccine revenue reaches $275m AstraZeneca said today that its Covid-19 vaccine contributed $275m in sales and shaved off three cents per share from its first-quarter earnings. Business • 30 Apr 21
EU may not order further AstraZeneca Covid-19 vaccines The European Union's internal markets commissioner Thierry Breton has hinted that the bloc might decide not to order AstraZeneca's coronavirus jab again following delays in … Astrazeneca • 18 Apr 21
Australia says clotting death likely linked to AZ jab Australia has reported its first fatality from blood clots in a recipient of AstraZeneca's Covid-19 shot, and its regulator said there was a likely link … Coronavirus • 16 Apr 21
What happens now after new AstraZeneca advice? It is important not to overstate the impact of the latest recommendation for the AstraZeneca vaccine on the national immunisation campaign. Coronavirus • 13 Apr 21
NIAC recommends restriction of AZ jab to over-60s The National Immunisation Advisory Committee (NIAC) has recommended that only people over 60 years of age should get the AstraZeneca Covid-19 vaccine. Coronavirus • 12 Apr 21
EU looks to secure 1.8bn 2nd-generation vaccine doses The EU is about to start negotiations with a single pharmaceutical company to secure up to 1.8 billion doses of a "second generation" mRNA vaccine … Coronavirus • 09 Apr 21
16 reports of blood clots following AZ vaccine - HPRA The Health Products Regulatory Authority has said it has received 16 reports of blood clots occurring following vaccination with the AstraZeneca Covid-19 vaccine. Coronavirus • 06 Apr 21
Norway delays AstraZeneca vaccine decision for 3 weeks Norway will delay a decision on whether to resume the use of AstraZeneca's Covid-19 vaccine until 15 April, the Norwegian Institute of Public Health has … Coronavirus • 26 Mar 21
France accuses UK of 'blackmail' over vaccine supplies French Foreign Minister Jean-Yves Le Drian said Europe would not let itself be subjected to "a kind of blackmail" by Britain over supplies of Covid-19 … Coronavirus • 26 Mar 21
AstraZeneca says vaccine 76% effective in updated data AstraZeneca has revised down by three percentage points the effectiveness of its Covid vaccine after American authorities raised concerns that results reported from its US … Coronavirus • 25 Mar 21
